Detalhe da pesquisa
1.
Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation.
Immunity
; 53(1): 98-105.e5, 2020 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32561270
2.
Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain.
Sci Adv
; 8(18): eabm3948, 2022 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507661
3.
Adjuvants influence the maturation of VRC01-like antibodies during immunization.
iScience
; 25(11): 105473, 2022 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36405776
4.
Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit.
Commun Biol
; 5(1): 342, 2022 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35411021
5.
Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies.
Cell Rep
; 35(5): 109084, 2021 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951425
6.
A single mRNA immunization boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.
medRxiv
; 2021 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758873
7.
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.
Science
; 2021 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33766944
8.
Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects.
bioRxiv
; 2021 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33791692
9.
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects.
Cell Rep
; 36(2): 109353, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34237283
10.
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study.
Science
; 374(6566): 472-478, 2021 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34554826
11.
Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual.
bioRxiv
; 2020 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32511342
12.
Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization.
Cell Rep
; 29(10): 3060-3072.e7, 2019 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31801073
13.
Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies.
Cell Rep
; 36(3): 109454, 2021 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289363